These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
90 related articles for article (PubMed ID: 2540909)
21. Is the glycine site half saturated or half unsaturated? Effects of glutamatergic drugs in schizophrenia patients. Javitt DC Curr Opin Psychiatry; 2006 Mar; 19(2):151-7. PubMed ID: 16612195 [TBL] [Abstract][Full Text] [Related]
22. [Neuropsychopharmacological study on an animal model for negative symptom of schizophrenia induced by repeated phencyclidine treatment]. Noda Y; Nabeshima T Yakugaku Zasshi; 2000 Aug; 120(8):677-82. PubMed ID: 10946617 [TBL] [Abstract][Full Text] [Related]
23. Dopamine-acetylcholine-glutamate interactions in the striatum. A working hypothesis. Di Chiara G; Morelli M Adv Neurol; 1993; 60():102-6. PubMed ID: 8093571 [No Abstract] [Full Text] [Related]
24. Non-NMDA receptor antagonists and the development of amygdala kindling. Meldrum BS; Dürmüller N Epilepsy Res Suppl; 1996; 12():283-91. PubMed ID: 9302527 [No Abstract] [Full Text] [Related]
25. Involvement of a dysfunctional dopamine-D1/N-methyl-d-aspartate-NR1 and Ca2+/calmodulin-dependent protein kinase II pathway in the impairment of latent learning in a model of schizophrenia induced by phencyclidine. Mouri A; Noda Y; Noda A; Nakamura T; Tokura T; Yura Y; Nitta A; Furukawa H; Nabeshima T Mol Pharmacol; 2007 Jun; 71(6):1598-609. PubMed ID: 17344353 [TBL] [Abstract][Full Text] [Related]
34. Hyperinnervation of orbital frontal cortex in schizophrenia. Deakin JF; Slater P; Simpson MD; Royston MC Br J Psychiatry; 1990 Sep; 157():459-60. PubMed ID: 1978787 [No Abstract] [Full Text] [Related]
35. [Dysfunction of glutamatergic systems and potential animal models of schizophrenia]. Mouri A; Noda Y; Mizoguchi H; Nabeshima T Nihon Yakurigaku Zasshi; 2006 Jan; 127(1):4-8. PubMed ID: 16508216 [No Abstract] [Full Text] [Related]
36. Selectivity of excitotoxic mechanisms in Alzheimer's disease. May PC Neurobiol Aging; 1989; 10(5):606-8; discussion 618-20. PubMed ID: 2572984 [TBL] [Abstract][Full Text] [Related]
37. [Metabolism and functions of brain D-serine in mammals: relevance to neuropsychiatric disorders]. Nishikawa T Seikagaku; 2008 Apr; 80(4):267-76. PubMed ID: 18516904 [No Abstract] [Full Text] [Related]
38. [Stimulating glutamatergic neurons as a potential novel therapeutic avenue for schizophrenia]. Nakato K; Harada K; Tobe T; Yamaji T; Takakura S Nihon Yakurigaku Zasshi; 2010 Sep; 136(3):128-32. PubMed ID: 20838012 [No Abstract] [Full Text] [Related]
39. Phencyclidine and schizophrenia. Kornhuber J Am J Psychiatry; 1992 Jun; 149(6):848-9. PubMed ID: 1350430 [No Abstract] [Full Text] [Related]
40. Pathogenesis of schizophrenia: loss of function of presynaptic inhibitory receptor sites. Schnieden H Med Hypotheses; 1977; 3(5):205-6. PubMed ID: 198642 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]